Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Denzel

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Archiv Der Pharmazie|March 1, 1974
[New synthesis of unknown 1-unsubstituted 1 H-pyrazolo(3.4-b)pyridin-5-carboxylates (author's transl)]T Denzel
Archiv Der Pharmazie|October 1, 1973
[Pyrazolo(4.3-c)pyridines (author's transl)]T Denzel, H Höhn
Archiv Der Pharmazie|June 1, 1976
[Synthesis of 1H-pyrazolo[3,4-b]pyridine-5-ketones (author's transl)]T Denzel, H Höhn
Archiv Der Pharmazie|June 1, 1975
[Isoxazolo(5.4-b)pyridines (author's transl)]W Janssen, T Denzel
Archiv Der Pharmazie|November 1, 1972
[Isoxazolo(5,4-b)pyridines]T Denzel, H Höhn
Leukemia|May 16, 2008
How little is too much? p53 inactivation: from laboratory cutoff to biological basis of chemotherapy resistanceT Zenz, S Häbe, T Denzel, et al.
British Journal of Haematology|April 16, 2008
Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutationsT Zenz, K Döhner, T Denzel, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complicationsM Goerner, H Wandt, K Schäfer-Eckart, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1981
Monobactams--structure-activity relationships leading to SQ 26,776H Breuer, C M Cimarusti, T Denzel, et al.
Bone Marrow Transplantation|May 7, 1999
Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancerH Wandt, J Birkmann, T Denzel, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Archiv Der Pharmazie|March 1, 1974
[New synthesis of unknown 1-unsubstituted 1 H-pyrazolo(3.4-b)pyridin-5-carboxylates (author's transl)]T Denzel
Archiv Der Pharmazie|October 1, 1973
[Pyrazolo(4.3-c)pyridines (author's transl)]T Denzel, H Höhn
Archiv Der Pharmazie|June 1, 1976
[Synthesis of 1H-pyrazolo[3,4-b]pyridine-5-ketones (author's transl)]T Denzel, H Höhn
Archiv Der Pharmazie|June 1, 1975
[Isoxazolo(5.4-b)pyridines (author's transl)]W Janssen, T Denzel
Archiv Der Pharmazie|November 1, 1972
[Isoxazolo(5,4-b)pyridines]T Denzel, H Höhn
Leukemia|May 16, 2008
How little is too much? p53 inactivation: from laboratory cutoff to biological basis of chemotherapy resistanceT Zenz, S Häbe, T Denzel, et al.
British Journal of Haematology|April 16, 2008
Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutationsT Zenz, K Döhner, T Denzel, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complicationsM Goerner, H Wandt, K Schäfer-Eckart, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1981
Monobactams--structure-activity relationships leading to SQ 26,776H Breuer, C M Cimarusti, T Denzel, et al.
Bone Marrow Transplantation|May 7, 1999
Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancerH Wandt, J Birkmann, T Denzel, et al.
Pageof 2